xpeer logo

© 2026 XPEER MEDED, S.L. · Av. del Portal de l'Àngel, 38, 4º 5ª, 08002 Barcelona, Spain · All rights reserved

Privacy Policy - Terms of Use - Help

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account
Course Preview

Health outcomes of drugs-gut microbiota interactions

4.9

Accredited (Credits: 1)
Free
1h 13min
Audio: English
Subtitles: Russian +4

Synopsis

Explore the intricate relationship between antibiotics and the human microbiome in this CME course, updated with the latest evidence in the field. Providing you with a more practical approach, the course now includes a clinical case revealing the profound impact of antibiotic therapy on gut health, and how relevant the knowledge acquired in this course will be to your clinical practice. Understand how dysbiosis, characterized by microbial imbalance, underpins various gastrointestinal and systemic disorders. Updated with cutting-edge research, discover novel insights into antibiotic-associated dysbiosis and its far-reaching consequences on patient health. Equip yourself with evidence-based strategies to mitigate dysbiosis-related complications and optimize patient outcomes. Join us to navigate the evolving landscape of drug-microbiome interactions in clinical practice. This activity is supported by an independent support grant from Biocodex Microbiota Institute.

Accreditation

This course is accredited with 1 ECMEC credit valid in 26 countries. To claim your credits take the evaluation (satisfaction survey and evaluation questionnaire). You have 3 attempts for the evaluation. You need to pass the evaluation with a sufficient score to validate the course. Your diploma is issued instantaneously and sent to your email.

See more information on the accreditation at: Accreditation

Duration

1h 13min

Target audience

Gastroenterology, Family medicine, General practice, Internal medicine

Authors

Prof Dr Francisco Guarner

Francisco Guarner, MD, PhD. has a degree in Medicine and Surgery and specialized in Digestive Diseases. He carries out his professional activity in the Digestive Pathology Service of the Universitari Vall d'Hebró Hospital. He has been a research fellow at the Liver United at Kings College Hospital in London and a research fellow in the Prostaglandin Research department of Welcome Research Laboratories. He is currently a member of the Centre of Network Biomedical Research of hepatic and digestive diseases as principal investigator of the inflammatory bowel diseases group and a member of the Board of Directors of the International Scientific Association for Probiotics and Prebiotics. He is also president of the Board of Directors of the Probiotics and Prebiotics Spanish Society, member of the Guidelines & Publications Committee of WGO-OMGE (World Gastroenterology Organization) and member of the Steering Committee of the International Human Microbiome Consortium (IHMC).

Conflicts of interests statement:

Francisco Guarner receives research funding from Abbvie, Takeda and AB-Biotics, and consulting fees from the Danone Institute, Sanofi, Biocodex, Actial, Menarini and Ordesa.

Testimonials

“Xpeer is a magnificent platform for healthcare professionals, where you can gain knowledge from a scientific and highly up-to-date perspective across various medical specialties.”

Wil A. onTrustpilot

Netherlands

“I've taken several courses on Xpeer and they've been very useful. The format is very dynamic, allowing you to watch the videos in your free time since they're no longer than 15 minutes. The topics are very current.”

Francisco P. onTrustpilot

Spain

“Excellent platform to stay up to date and keep learning throughout your professional career. I recommend it to all my colleagues.”

Omar I. onTrustpilot

Spain

Read more reviews onTrustpilot

FAQs

What you will learn

Before you begin

  • Pre-course assessment: please complete to help us personalise your learning experience

Trailer

  • Trailer

Introduction

  • Clinical case
  • Dysbiosis: the concept

Impact of antibiotics on gut microbiota

  • Antibiotic induced dysbiosis
  • Short-term side-effects of antibiotics
  • Potential long-term consequences

Impact of other substances

  • PPIs-induced dysbiosis
  • Metmorfin, statins, sweeteners

Impact of microbiota on gut response

  • Pharmacomicrobiomics

Conclusions

  • 3 recommendations & 3 things to reconsider

Accreditation - Evaluation

  • Satisfaction survey
  • Multiple-choice test

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account